Vicapsys Life Sciences, Inc. VICP
0.50 USD +0.05 (+11.11%)
At closeNov 2, 2026, 4:00 PM EST
0.20 Day range 0.60
0.1001 52-week range 1.50
- YTD
- -66.67%
- 1 year
- -66.67%
- Market cap
- 16.19M
- EPS (ttm)
- -0.01
- YTD return
- -66.67%
- 1-year return
- -66.67%
- Volume
- 3.08K
- Avg volume
- 1.36K
- Open
- 0.45
- Previous close
- 0.45
- Day's range
- 0.20 – 0.60
- 52-week range
- 0.1001 – 1.50
- Earnings date
- Oct 21, 2024
2Y -6.5000 (-92.86%)
Next earnings
Oct 21, 2024
Expected Oct 21, 2024. Consensus EPS estimate 0.00.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Oct 21, 2024 | Dec 1, 2023 | 0.00 | — | — | — |
| Aug 14, 2023 | Jun 1, 2023 | 0.00 | — | — | — |
| May 15, 2023 | Mar 1, 2023 | 0.00 | — | — | — |
| Aug 16, 2022 | Jun 1, 2022 | 0.00 | -0.01 | — | — |
| Sep 20, 2021 | Mar 1, 2021 | 0.00 | 0.00 | — | — |
| Sep 9, 2021 | Jun 1, 2020 | 0.00 | — | — | — |
News
Housekeeping Starts with Branding: Vicapsys Life Sciences Adopts New Corporate Identity Developed by FutureBrand for Vicapsys and Its Stateline Subsidiary 
Vicapsys Life Sciences Announces Advisory Board Following Completion of Stateline Merger 
RETRANSMISSION: Vicapsys Life Sciences Completes Reverse Merger with Stateline Distributors of Puerto Rico and Signs Definitive Agreement to Acquire NitroMist(R), Creating a Vertically Integrated Pharmaceutical Manufacturing and Distribution Platform Serving Federal, Tribal and Underserved Markets 
Vicapsys Life Sciences Completes Reverse Merger with Stateline Distributors of Puerto Rico and Signs Definitive Agreement to Acquire NitroMist(R), Creating a Vertically Integrated Pharmaceutical Manufacturing and Distribution Platform Serving Federal, Tribal and Underserved Markets
Your note
Sign in to keep a note on VICP — it syncs with the Stock Master app.